A novel biphasic oral contrast solution for enterographic studies.

Area of Science:

• Radiology
• Gastroenterology
• Medical Imaging

Background:

• Magnetic resonance enterography (MRE) is a key imaging modality for evaluating small bowel diseases.
• Optimizing oral contrast agents is crucial for improving image quality and diagnostic accuracy in MRE.
• Current biphasic oral contrast agents have varying degrees of efficacy and patient tolerance.

Purpose of the Study:

• To compare the efficacy and patient tolerance of a novel mixed biphasic oral contrast solution against a standard biphasic agent in MRE.
• To assess the impact of the new contrast agent on image quality parameters and diagnostic confidence.

Main Methods:

• A comparative study involving 37 patients receiving the new mixture and 14 patients receiving lactulose for MRE.
• Radiological assessment of luminal distension, wall conspicuity, and evaluation confidence by two independent radiologists.
• Statistical analysis using the Mann-Whitney U test and assessment of interrater/intrarater agreement.
• Evaluation of patient-reported acceptability and tolerance.

Main Results:

• The new mixed biphasic contrast solution significantly improved luminal distension, wall conspicuity, and radiological evaluation confidence compared to the standard agent.
• Interrater and intrarater agreement for image scoring demonstrated generally moderate reliability.
• Patient tolerance and acceptability of the new mixture were favorable.

Conclusions:

• The novel mixed biphasic oral contrast solution yields high-quality enterographic images suitable for clinical use.
• This new agent is well-tolerated by patients and effective for evaluating both small bowel and colonic segments.
• The study recommends the adoption of this new mixture for routine enterographic examinations.